Back to top
more

Alger Health Sciences Fund Class A: (MF: AHSAX)

(NASDAQ Mutual Funds) As of May 22, 2026 06:14 PM ET

$22.88 USD

+0.06 (0.26%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

4-Sell of 5       4  

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Apr 30, 2026

Total Return %* Percentile Rank Objective
YTD -0.57 27
3 months -0.57 24
6 months 7.23 20
1 Year 22.54 23
3 Year 2.78 88
5 Year -2.76 96
10 Year 9.03 44

* Annual for three years and beyond.

Zacks Premium Research for AHSAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Sell 4
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 8.51
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 4/30/2026 44.06
% Turnover 4/30/2026 289.28

Risk

3 Year 5 Year 10 Year
Beta 0.78 0.70 0.78
Alpha -12.73 -11.43 -2.29
R Squared 0.42 0.40 0.42
Std. Dev. 15.09 16.96 18.20
Sharpe -0.11 -0.31 3.00

Sector / Country Weightings

As of 4/30/2026 % of Portfolio
Health 59.28
Services 16.36
Retail Trade 7.99
Other 4.88
Technology 4.56
Industrial Cyclical 3.89
Finance 3.04

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2026)		 % of Portfolio Value (Mil$)
FORTE BIOSCIENCES INC 5.50 3.54
TEVA PHARMACEUTICAL SP AD 4.75 3.05
ELI LILLY & CO 4.60 2.96
CARDINAL HEALTH INC 4.55 2.93
IMPULSE DYNAMICS PLC 4.32 2.78
BIOGEN INC 3.89 2.50
ASTRAZENECA PLC 3.80 2.45
CENTENE CORP 3.62 2.33
ARROWHEAD PHARMACEUTICALS 3.55 2.28

Stock Holding % of Net Assets

As Of 1/31/2026
Total Issues 53
Avg. P/E 26.16
Avg. P/Book 4.89
Avg. EPS Growth 15.31
Avg. Market Value (Mil $) 119,001

Composition

% of Portfolio
Stocks 95.35
Foreign Stocks 12.44
Cash 0.52
Bonds 0.00
Foreign Bonds 0.00
Preferred 4.32
Convertible 0.00
Other -0.19
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.26
Large Value 0.00
Small Growth 13.02
Small Value 0.42
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.65
Intermediate Bond 25.57
Foreign Bond 17.49
High Yield Bond 0.00